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Edited by Hans-Dieter KlenkAbstract The matrix protein M of Borna disease virus (BDV)
is a constituent of the viral envelope covering the inner leaﬂet
of the lipid bilayer. BDV-M was expressed as recombinant pro-
tein in Escherichia coli, puriﬁed to homogeneity and structurally
analyzed. Recombinant M (i) forms non-covalently bound multi-
mers with a Stokes radius of 35 A˚ estimated by size exclusion
chromatography, (ii) consists of tetramers detected by analytical
ultracentrifugation, and (iii) appears by electron microscopy
studies as tetramers with the tendency to assemble into high
molecular mass lattice-like complexes. The structural features
suggest that BDV-M possesses a dominant driving force for virus
particle formation.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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structure1. Introduction
Viral matrix proteins are constituents of most enveloped
viruses forming a layer at the inner side of the viral envelope.
Matrix proteins attract increasing interest because they are the
most abundant structural components of the virus envelopes
and play a critical role in the process of virus assembly and
budding at the plasma membrane. They are also assumed to
be responsible for viral shape maintenance. It is generally ac-
cepted that matrix proteins play an important role in interac-
tion with ribonucleoprotein (RNP) and with intraviral amino
acid sequences of envelope glycoproteins [1]. Furthermore,
matrix proteins are involved in regulation of virus replication
and in RNP transport to the cellular membrane for generation
of virus progeny as, for instance, demonstrated with the inﬂu-
enza virus matrix protein [2]. Currently, increasing data are
available which indicate that matrix proteins are responsible
for an active release of virus particles. This was shown, for
example, for HIV, Ebola- and Lassavirus among other envel-
oped viruses [3–5]. Structures of some viral matrix proteins
were elucidated at the atomic level, e.g. HIV, inﬂuenza virus,
and two representatives of the order Mononegavirales, Vesicu-Abbreviations: BD, Borna disease; BDV, Borna disease virus; M,
matrix protein; SDS–PAGE, Sodium dodecylsulfate polyacrylamide
gel electrophoresis
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Ebola virus matrix protein is assembled at the lipid membrane
it changes its conformation and acquires speciﬁc RNA binding
characteristics [10–12]. In order to elucidate whether viral ma-
trix proteins are arranged principally in similar or diﬀerent
types of arrays it is of interest to analyze several various envel-
oped viruses. In this respect, we investigated the matrix protein
M of Borna disease virus (BDV).
BDV is the only representative of the Bornaviridae family
within the order Mononegavirales, which also includes mea-
sles-, rabies-, Ebola-, Marburg viruses and numerous other
important pathogenic viruses. BDV is the etiological agent of
Borna disease (BD), a sporadically occurring, progressive viral
encephalomyelitis that primarily aﬀects horses and sheep. Dur-
ing the last decades, infection of BDV was observed in an
increasing number of domestic and zoo animals worldwide.
Serological evidence of BDV infection has been found in
numerous countries throughout the world. After an incubation
period lasting a few weeks to several months, BDV infection
can cause locomotor and sensory dysfunctions followed by
paralysis and death. BD is the result of virus-induced immuno-
pathological reactions. BDV-speciﬁc antibodies and viral
RNA have been found in humans with various psychiatric dis-
eases. But it is still unclear, whether BDV causes any illness in
man [13,14].
BDV is an enveloped, single-stranded RNA virus containing
the smallest genome of negative sense among the Mononegavi-
rales which also reﬂects the smallest virus-coded proteins, espe-
cially the matrix protein M. BDV is characterized by nuclear
transcription and replication and by using RNA splicing
machinery of host cells which is unique within this virus order.
The BDV genome consists of at least six open reading frames
(ORFs). They code for p40/38 nucleoprotein (N) (ORF I), p24
phosphoprotein (P) (ORF II), p16 matrix protein (M) (ORF
III), p57 glycoprotein (GP) (ORF IV), RNA polymerase (L)
(ORF V), and p10 protein (X) (ORF VI). GP, previously de-
signed as gp84, gp94 or G, is the N-glycosylated precursor of
p57. GP is proteolytically cleaved into the complex GP-N/
GP-C which is present in the mature virus particles as spikes
[15]. Proteins N, P, X and L are associated with the RNA gen-
ome forming the RNP-complex [16]. Previously, it was as-
sumed that p16 of ORF III encodes a viral glycoprotein
(gp16) [17,18]. However, a reinvestigation of the gene product
of ORF III revealed that p16 is a non-glycosylated membrane
protein which can be detached from lipid bilayers without
detergents. These characteristics showed that p16 is the viral
matrix protein M [19]. BDV possesses the smallest matrix
protein with a molecular mass of 16 258 kDa among allation of European Biochemical Societies.
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sequence similarity to other matrix proteins. Recombinant
BDV-M was expressed in Escherichia coli (E. coli), puriﬁed
and crystallized [20]. The elucidation of the X-ray structure
of BDV-M is currently in progress.
Here, we report how M oligomerizes and is assembled to a
high-order protein layer by diﬀerent physical–chemical protein
analyses.2. Materials and methods
2.1. Cloning, expression, and puriﬁcation of the BDV-M protein
The full-length BDV-M gene was isolated from viral RNA of BDV-
strain He/80 and cloned into the expression vector pMAL-c2 (New
England Biolabs) by using a RT-PCR technique as described before
[20]. The desired maltose binding protein fused to BDV-M (MBP-
BDV-M) was obtained after transformation of E. coli BL21 cells with
the recombinant vector pMAL-c2/BDV-M. MBP-BDV-M was puri-
ﬁed from lysed E. coli cells by aﬃnity chromatography using amylose
bound to carrier-beads. The BDV-M moiety containing N-terminally
the hexapeptide ISEFGS due to the cloning strategy was cleaved oﬀ
from MBP-BDV-M by factor Xa (Amersham Biosciences). BDV-M
was further puriﬁed to homogeneity by using MonoS HR 5/5 chroma-
tography and size exclusion chromatography via a HiLoad 16/60
Superdex 75 column and Superdex 200 HR 10/30 column, respectively
(Amersham Biosciences). All chromatography applications were per-
formed with an A¨KTAe FPLC System (Amersham Biosciences). Fi-
nally, puriﬁed BDV-M was concentrated to 5 mg per ml by using
Centricon-10 (Millipore).2.2. Electrophoresis of BDV-M under native and denaturating conditions
Separation of the basic BDV-M protein under native conditions
was performed on a 15% polyacrylamide gel in the presence of
1.6% acetic acid adjusted with KOH to pH 4.0. The separation
gel was overlaid by a 3.75% stacking polyacrylamide gel containing
0.54% acetic acid adjusted to pH 4.0. The M protein sample was di-
luted in sample buﬀer consisting of 40 mM b-alanine adjusted with
acetic acid to pH 4.0, containing 10% glycerol and 0.04% methyl-
green. Gel electrophoresis was performed at 150 V for 3 h at room
temperature [21]. Electrophoretic separation of BDV-M under dena-
turing conditions was performed on a 15% polyacrylamide gel con-
taining 0.1% SDS and ß-mercaptoethanol after heating of the
protein M sample at 96 C for 5 min [22].2.3. Determination of stoke radius of protein M by size exclusion
chromatography
Protein M fractions of unknown molecular mass were dissolved in
separation buﬀer containing 50 mM HEPES, 150 mM NaCl, pH 7.6
and passed through a Superdex 200 HR 10/30 column according to
manufacturers instructions using an A¨KTA FPLC System (Amer-
sham Biosciences). Protein standards from the Low and High
Molecular Weight Gel Filtration Calibration Kit (Amersham Biosci-
ences) were separated under identical conditions. Each eluted single
protein peak was monitored by measurement of optical density at
280 nm. The collected data were presented as the plot of
(log Kav)1/2 versus Stokes radius according to the Laurent and Kil-
lander solution [23].Fig. 1. (A) Gel ﬁltration chromatography of recombinant BDV-M.
Elution proﬁle of puriﬁed M passed through Superdex 75 column, UV
adsorption at 280 nm. (B) Native and denaturating polyacrylamide gel
electrophoresis. Fraction F17 and F20 from Superdex 75 column
subjected to native (lanes 1 and 2) and 15% SDS–PAGE (lanes 3 and
4). Positions of molecular weight marker proteins are indicated for
electrophoretic separation in polyacrylamid gels under denaturating
conditions.2.4. Chemical cross-linking of oligomerized protein M
Puriﬁed BDV-M (5 lg/ll) was supplemented with 0.2 M triethanol-
amine pH 8.0. Dimethyl pimelinimiate-HCl (DMP, Sigma) was freshly
dissolved in 0.2 M triethanolamine to yield a 0.5 mM DMP solution
which was adjusted to pH 8.0 by addition of 0.1 N NaOH. 5 lg
(1 ll) BDV-M (pH 8.0) was mixed with 2 ll of DMP solution (pH
8.0) and incubated for 10 min at 10 C. Thereafter the cross-linking
reaction was quenched by addition of 1 ll of 2.2 M triethanolamine,
mixed with 4 ll Laemmli 4· sample buﬀer prior to subjection to 15%
SDS–PAGE. The protein was analyzed by Coomassie Brilliant Blue
R250 staining.2.5. Matrix-assisted laser desorption ionisation-time of ﬂight mass
spectrometry
Puriﬁed BDV-M protein samples were desalted by NAP-10 columns
(Amersham-Biosciences), and about 1 lMol of each protein sample
was embedded in saturated sinapic acid in 0.1% (v/v) triﬂuoroacetic
acid, 67% (v/v) acetonitril. For each spectrum, at least 100 single shots
were totalized. The spectra were determined with a Voyager DE RP
from PE-Biosystems.
2.6. Analytical ultracentrifugation
Sedimentation analyses were conducted using an analytical ultracen-
trifuge Optima X-LA (Beckman Instruments, Palo Alto, CA) equipped
with two channel cells and an AnTi 50 rotor. The protein concentra-
tion varied between 10 and 500 lg per ml. Dilutions of recombinant
M were performed with 50 mM HEPES buﬀer pH 7.6 containing
150 mM NaCl. Centrifugation velocity was performed at 40 000 rpm
at 20 C. Centrifugation equilibrium was measured at 12 000 rpm,
20 C. The samples were monitored at 230 and 280 nm, respectively.
The apparent s-values and molecular masses were calculated using
the software provided by Beckman Instruments. The dependence
of the apparent s-values on the protein concentration was ﬁtted
according to Luther and co-workers [24] assuming a tetramer octamer
equilibrium.
2.7. Electron microscopy
Indirect carbon support ﬁlms were prepared as described previously
[25]. Puriﬁed full-length recombinant M protein was applied to the car-
bon prior to negative staining with an aqueous solution of 4% (w/v)
uranyl acetate. The stained specimen was mounted onto a 400 mesh
copper grid. Each specimen was observed in a Zeiss EM T109 electron
2688 I. Kraus et al. / FEBS Letters 579 (2005) 2686–2692microscope operated at an acceleration voltage of 80 kV. Electron
micrographs were recorded at a calibrated magniﬁcation (48 200·,
by using a cross-ruled diﬀraction grating replica with 2160 lines/mm).3. Results
3.1. Puriﬁcation of BDV-M protein
Isolation of BDV-M in pure form is not feasible from virus
preparations because BDV propagation in cell cultures is very
ineﬃcient. Furthermore, the BDV particles are very instable,
thus not allowing extensive puriﬁcation of virus preparations.
Therefore, studies of oligomerization and assembly of full-
length BDV-M under physiological conditions were performed
with E. coli recombinant BDV-M. The M gene was obtained
from permanently BDV infected mammalian cell cultures by
RT-PCR technique. Recombinant BDV-M was then expressed
in E. coli as a fusion protein linked to maltose binding protein
(MBP). After BDV-M was cleaved oﬀ from the fusion protein,
it was subjected to several chromatographic puriﬁcation steps
including maltose resin, ion exchange chromatography, and
size exclusion chromatography using a Superdex 75 gel perme-
ation column. BDV-M was observed in two peak maxima, i.e.
in fractions 17 and 20 (Fig. 1A). The 280–260 nm ratio of
about 1.1 indicated that these fractions might contain oligonu-Fig. 2. (A) Mass spectrum of BDV-M. MALDI-TOF-MS spectrum is shown
as matrix. The 100% scale of the relative intensities refers to 14 000 counts.
proteins. UV adsorption at 280 nm, arrows indicate elution volumes of the
chymotrypsinogen A (25 kDa, 20.9 A˚), O: ovalbumin (43 kDa, 30.5 A˚), B:
(232 kDa, 52.2 A˚), F: ferritin (440 kDa, 61 A˚), T: thyroglobulin (669 kDa, 85
of M from fraction 20 (see B). The Stokes radius of M was calculated as 35cleotides incorporated in M oligomers, since VP 40 of Ebola
virus was found to bind a triribonucleotide [12]. Fractions 17
and 20 of the Superdex 75 column were subjected to gel elec-
trophoresis under native and denatured conditions. Fraction
17 shows predominantly a form with poor electrophoretic
mobility, whereas fraction 20 exhibits a higher mobility indi-
cating a smaller complex (Fig. 1B, lane 1 and 2). In both frac-
tions only one protein band with a molecular mass of 16 kDa
under denaturing conditions was obtained (Fig. 1B; lane 3 and
4). This result demonstrated that BDV-M was puriﬁed nearly
to homogeneity, but it exist in at least two multimeric forms.
3.2. Homooligomerization of BDV-M
Puriﬁed BDV-M of fraction 20 of the Superdex 75 column
was also analyzed by mass spectrometry in order to clarify
the molecular mass of M in this fraction. The matrix-assisted
laser desorption ionisation-time of ﬂight (MALDI-TOF) anal-
ysis of M of fraction 20 revealed the maximal molecular
masses of 16 875 for M (Fig. 2A), which diﬀers only by
3.5 Da from the calculated molecular mass of 16 878.5.
Both fractions of the Sephadex 75 column were subjected to
a re-chromatography on a Superdex 200 HR 10/30 column,
calibrated with molecular mass markers. Re-chromatography
resulted in a peak with the same elution volume for both frac-
tions (Fig. 2B). The Stokes radius of protein M was calculatedfor Superdex 75 fraction F20. Spectrum was collected with sinapic acid
(B) Rechromatography of F20 on Superdex 200 column and standard
following standard proteins: R: ribonuclease A (13.7 kDa, 16.4 A˚), C:
albumin (67 kDa, 35.5 A˚), A: aldolase (158 kDa, 48.1 A˚), K: catalase
A˚) and D: Blue Dextran 2000. (C) Determination of the Stokes radius
A˚.
I. Kraus et al. / FEBS Letters 579 (2005) 2686–2692 2689by the elution volumes of fraction 20 and the elution volumes
of the marker proteins indicated in Fig. 2B. The Stokes radius
of M was determined as 35 A˚ (Fig. 2C), that would ﬁt a BDV-
M tetramer.
M protein from fraction 20 was already used for crystalliza-
tion of M [20]. Since no higher molecular mass species were de-
tected for M by mass spectrometry, oligomer formation of M
in fraction 17 and 20 of Superdex 75 column must be based on
non-covalent interactions. Taken the data of gel permeation
chromatography, gel electrophoresis and mass spectrum anal-
yses together, it is reasonable to speculate that protein M exist
in a non-covalently oligomeric form.Fig. 3. Analytical ultracentrifugation. (A) Molecular mass of BDV-
M. Molecular mass determination of BDV-M F20 was performed by
sedimentation equilibrium measurement at 10 000 rpm, 20 C in an3.3. Sizing of oligomerized BDV-M
Analytical ultracentrifugation analysis is the appropriate
method to accurately determine the molecular mass of the oli-
gomerized BDV-M independently of gel permeation chroma-
tography. The two distinct peaks from the gel ﬁltration of
BDV-M on Sephadex 75 column were analyzed by analytical
ultracentrifugation. The protein of the elution peak fraction
20 consists of a homogeneous species of Mr = 65 200 ± 1850
(Fig. 3A). This molecular mass ﬁts well to a tetrameric state
of BDV-M with a theoretical mass of 67 500. Neither the
apparent molecular mass nor the s-value of sedimentation
velocity (sapp = 3.57 S) were dependent on the protein concen-
tration at a range of 0.05–0.5 mg/ml, proving the tetramer as
the stable structural unit of this protein.
In contrast to this result, the viral protein of the gel ﬁltration
peak 17 showed a faster apparent sedimentation velocity and a
signiﬁcant variation of the s-value with protein concentration
(Fig. 3B). This dependency could be ﬁtted to a tetramer–
octamer equilibrium and a dissociation constant of KD =
0.6 lM. However, the data do not rule out that at higher
protein concentrations (>0.5 mg/ml) even larger association
states of the tetrameric unit might occur, which are built by
the stable tetrameric unit of BDV-M.analytical ultracentrifuge. The protein concentration was 0.3 mg/ml.
The experimental data (dots) could be ﬁtted (solid line) to a
homogeneous species with a calculated mass of 65 160 Da, represent-
ing a stable tetramer. (B) Association state of BDV-M. The
dependence of the apparent s-value of sedimentation of BDV-M on
the protein concentration was measured at 40 000 rpm, 20 C.
Whereas the sedimentation velocity of BDV-M F20 was independent
of the protein concentration (), the species BDV-M F17 displayed an
increase in the s-value with increasing concentration (). These data
could be described by a tetramer–octamer equilibrium with a
dissociation constant of 0.6 lM (solid line), assuming a starting
value at very low protein concentrations identical to that of BDV-M
F20.3.4. Assembly of oligomeric forms of BDV-M
In order to answer the question whether higher oligomeric
forms of BDV-M exist, M fractions were analyzed by chem-
ical cross-linking and electron microscopy. Cross-linking of
puriﬁed BDV-M fraction 20 of the gel permeation chroma-
tography shown in Fig. 1 resulted in a slightly diﬀerent
SDS-denatured state of the monomer, leading to a shift in
electrophoretic multimers indicating preformed M of higher
order (Fig. 4A). Therefore, it was interesting to analyze
whether unspeciﬁed oligomers accumulate or regular arrays
of BDV-M may be visible. Although the molecular size of
M is at the lower limit for electron microscopic analyses
of M-oligomers, these studies were performed with puriﬁed
recombinant BDV-M of fraction 20 and presented in two
overviews (Fig. 4B-1 and B-6). The majority of the particles
was homogeneous and formed elementary units of tetramers
which exhibit a characteristic central hole. The dimension of
a tetramer is consistent with the molecular mass of 16 kDa
for monomers and about 60 kDa for tetramers [26]. How-
ever, at this stage of optical resolution it cannot be excluded
that M-tetramers may not be distinguishable from octamers
formed by head-to-head dimerized tetramers (Fig. 4B-3 to
B-5). Furthermore, the tetramers of M are partially arranged
to short regular two-dimensional various geometric featuresin several areas of the overview micrograph (Fig. 4B1 and
B-6). Several possibilities of those tetrameric BDV-M
arrangements are schematically depicted (Fig. 4B-7). In gen-
eral, the analysis of proteins by electron microscopy was
developed for macromolecules of the size of haemoglobin,
for instance, but the results obtained with BDV-M were
convincing. However, based on the limited resolution the
particle analysis does not unambiguously show which types
of lattices prevail.
In conclusion, our data clearly indicate that E. coli recombi-
nant M protein of BDV exists as stable non-covalently linked
tetramers which rudimentarily assemble to net-like structures.
Fig. 4. (A) Chemical cross-linking of recombinant BDV-M. Electrophoresis of recombinant BDV-M of fraction 20 of Sephadex 75 column
chromatography is shown before and after chemical cross-linking. Puriﬁed M was kept untreated () or treated (+) with the cross-linker DMP and
subjected to 15% SDS–PAGE. The proteins were stained with Coomassie Brilliant Blue. The positions of recombinant standard proteins are
indicated. (B) Electron microscopic analysis of puriﬁed, full-length BDV-M. M was negatively stained with 4% (w/v) uranyl acetate. Overview of M
oligomers (1, 6), typical tetrameric M (2), possible octamer (3), models of tetramer (4) and octamer (5), M forming characteristic rudimentary lattices
(6), and models depicted from (6) of regular two-dimensionally assembled M (7).
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Virus assembly requires the transport of many viral compo-
nents to the assembly site where they are concentrated and
segregated from cellular components so that interactions be-
tween viral components become more and more likely. Pri-
mary weak interactions between single or preformed viral
components enhance and amplify the co-operations among
them. Assembly of enveloped viruses depends on selective
association of viral proteins at two-dimensional lipid bilayers
[27]. In this assembly process viral matrix proteins play a cen-
tral role. They exhibit a scaﬀolding layer lined on the inner
lipid surface of the virus envelope. In recent years, the struc-
ture and function of viral matrix proteins in connection with
the late step of virus budding from cellular membranes be-came of high interest [28]. BDV has the smallest genome
among the Mononegavirales and accordingly the shortest ami-
no acid sequences of the corresponding gene products. It is
therefore a suitable model for understanding the function
of the BDV-M and other interacting BDV proteins at the
atomic level. The BDV matrix- and nuclear protein were crys-
tallized and the crystal structure of the nucleoprotein was
successfully elucidated, the ﬁrst one among all negative sin-
gle-stranded RNA viruses [20,29].
Previously, we demonstrated that recombinant BDV-M iso-
lated from the soluble cytoplasmic fraction of E. coli has the
same electrophoretic mobility as M of BDV-infected material
under denaturing conditions (data not shown). Here, we show
that BDV-M forms tetramers as the most stable elementary
unit of M under physiological conditions. This is independently
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ultracentrifugation. The lack of cysteine residues in BDV-M ex-
cludes oligomers which might be formed by disulﬁde bonds.
Denaturing gel electrophoresis of M reveals a band with about
15 kDa, indicating a monomer of BDV-M. Chemical cross-
linking experiments of M under physiological conditions shift
the monomer to dimers, tetramers, and other multimers of M
reﬂecting its tendency for self-assembly. In addition, MAL-
DI-TOF analysis reveals non-covalently bound monomers of
all forms of recombinant BDV-M. Since the mass spectroscopy
of the diﬀerent BDV-M size-species obtained by gel permeation
chromatography resulted always in the identical mass of M,
only non-covalent bonds are responsible for the diverse associ-
ation behavior of M.
Interestingly, diﬀerent size-species of M only appeared after
long incubation at high salt concentration in two fractions of
the Mono S column. The re-chromatography of each of the
two fractions through a Mono S column results in two peaks
again. These observations indicate that equilibrium between
tetramers and octamers of BDV-M exists due to its weak
reversible binding forces, which is also supported by the ultra-
centrifugation studies.
Our electron microscopic studies independently demonstrate
the tendency of BDV-M to form stable tetramers and extended
complexes based on lateral contacts under physiological condi-
tions. Our previous ﬁndings of the cubic space group I432 of
the M-crystals is also consistent with this view of a higher or-
dered BDV-M assembly based on tetrameric elementary units
[20]. The ability to form stable non-covalent tetramers that are
capable of either forming two- and three-dimensional lattices
implicate that BDV-M may be the driving force for virus par-
ticle formation.
Whereas M proteins of VSV and inﬂuenza virus are mono-
meric in solution or tend to form very large aggregates
[30,31], BDV-M forms multimers in solution like Ebola ma-
trix protein. The crystal structure of Ebola virus VP40 exhib-
its disc-shaped octamers which are formed by four
antiparallel homodimers of the N-terminal domain [12]. The
combination of x-ray crystallography on viral matrix proteins
and electron microscopic images of negatively stained parti-
cles has proved to be a powerful approach to clarify the
architecture of the matrix protein layer beneath the lipid layer
of a few envelope viruses. At least two diﬀerent principles
have been discerned for matrix protein assisted shape control:
(i) the multimerization of a regular array of oligomers to
form a net, as suggested for VP40 of Ebola virus, and (ii) a
repetitive addition of staggered oligomers to form a ﬂexible
ribbon forming a helix as found for inﬂuenza virus M1.
The data presented here suggest that BDV-M may most
likely follow the same rules as found for Ebola virus VP40
matrix formation. It is yet not clear, whether BDV-M binds
oligonucleotides as it was found with the Ebola virus matrix
protein VP40 which binds speciﬁc trinucleotides [32].
Interestingly, the nucleoprotein N [29] and the M of BDV
form tetramers in solution. Physiological function of tetramer-
ization of both proteins and their correlation will be further
investigated.
In conclusion, we could demonstrate that recombinant BDV-
M forms stable tetramers which have the tendency to assemble
to geometric regular two-dimensional structures, indicating
that M of BDV is the driving force for virus particle
formation.Acknowledgements: We thank R. Thauer and J. Kahnt from the Max-
Planck-Institut fu¨r Terrestrische Mikrobiologie, Marburg for help with
the mass spectrometry. This work was supported by the Deutschen
Forschungsgemeinschaft, SFB 535, A3; Ga 282/3-4, and Graduierten-
kolleg Proteinfunktion auf atomarer Ebene, Marburg.References
[1] Garoﬀ, H., Hewson, R. and Opstelten, D.J. (1998) Virus
maturation by budding. Microbiol. Mol. Biol. Rev. 62, 1171–
1190.
[2] Martin, K. and Helenius, A. (1991) Nuclear transport of inﬂuenza
virus ribonucleoproteins: the viral matrix protein (M1) promotes
export and inhibits import. Cell 67, 117–130.
[3] Martin-Serrano, J., Zang, T. and Bieniasz, P.D. (2001) HIV-1 and
Ebola virus encode small peptide motifs that recruit Tsg101 to
sites of particle assembly to facilitate egress. Nat. Med. 7, 1313–
1319.
[4] Mu¨ller, B., Patschinsky, T. and Kra¨usslich, H.G. (2002) The late-
domain-containing protein p6 is the predominant phosphoprotein
of human immunodeﬁciency virus type 1 particles. J. Virol. 76,
1015–1024.
[5] Strecker, T., Eichler, R., Meulen, J., Weissenhorn, W., Klenk,
H.D. and Garten, W., et al. (2003) Lassa virus Z protein is a
matrix protein and suﬃcient for the release of virus-like particles.
J. Virol. 77, 10700–10705.
[6] Hill, C.P., Worthylake, D., Bancroft, D.P., Christensen, A.M.
and Sundquist, W.I. (1996) Crystal structures of the trimeric
human immunodeﬁciency virus type 1 matrix protein: implica-
tions for membrane association and assembly. Proc. Natl. Acad.
Sci. USA 93, 3099–30104.
[7] Sha, B. and Luo, M. (1997) Structure of a bifunctional
membrane-RNA binding protein, inﬂuenza virus matrix protein
M1. Nat. Struct. Biol. 4, 239–244.
[8] Gaudier, M., Gaudin, Y. and Knossow, M. (2002) Crystal
structure of vesicular stomatitis virus matrix protein. EMBO J.
21, 2886–2892.
[9] Dessen, A., Volchkov, V., Dolnik, O., Klenk, H.D. and Weiss-
enhorn, W. (2000) Crystal structure of the matrix protein VP40
from Ebola virus. EMBO J. 19, 4228–4236.
[10] Scianimanico, S., Schoehn, G., Timmins, J., Ruigrok, R.H.,
Klenk, H.D. and Weissenhorn, W. (2000) Membrane association
induces a conformational change in the Ebola virus matrix
protein. EMBO J. 19, 6732–6741.
[11] Timmins, J., Ruigrok, R.W. and Weissenhorn, W. (2004) Struc-
tural studies on the Ebola virus matrix protein VP40 indicate that
matrix proteins of enveloped RNA viruses are analogues but not
homologues. FEMS Microbiol. Lett. 233, 179–186.
[12] Gomis-Ruth, F.X., Dessen, A., Timmins, J., Bracher, A., Koles-
nikowa, L. and Becker, S., et al. (2003) The matrix protein VP40
from Ebola virus octamerizes into pore-like structures with
speciﬁc RNA binding properties. Structure (Camb) 11, 423–433.
[13] Richt, J.A., Grabner, A. and Herzog, S. (2000) Borna disease in
horses. Vet. Clin. North Am. Equine Pract. 16, 579–595.
[14] Staeheli, P., Sauder, C., Hausmann, J., Ehrensperger, F. and
Schwemmle, M. (2000) Epidemiology of Borna disease virus. J.
Gen. Virol. 81, 2123–2135.
[15] Kiermayer, S., Kraus, I., Richt, J.A., Garten, W. and Eickmann,
M. (2002) Identiﬁcation of the amino terminal subunit of the
glycoprotein of Borna disease virus. FEBS Lett. 531, 255–258.
[16] Richt, J.A. and Rott, R. (2001) Borna disease virus: a mystery as
an emerging zoonotic pathogen. Vet. J. 161, 24–40.
[17] Kliche, S., Briese, T., Henschen, A.H., Stitz, L. and Lipkin, W.I.
(1994) Characterization of a Borna disease virus glycoprotein,
gp18. J. Virol. 68, 6918–6923.
[18] Stoyloﬀ, R., Bode, L., Borchers, K. and Ludwig, H. (1998)
Neutralization of borna disease virus depends upon terminal
carbohydrate residues (alpha-D-man, beta-D-GlcNAc) of glyco-
proteins gp17 and gp94. Intervirology 41, 135–140.
[19] Kraus, I., Eickmann, M., Kiermayer, S., Scheﬀczik, H., Fluess,
M. and Richt, J.A., et al. (2001) Open reading frame III of borna
disease virus encodes a nonglycosylated matrix protein. J. Virol.
75, 12098–12104.
2692 I. Kraus et al. / FEBS Letters 579 (2005) 2686–2692[20] Kraus, I., Scheﬀczik, H., Eickmann, M., Kiermayer, S., Stubbs,
M.T. and Garten, W. (2002) Crystallization and preliminary X-
ray analysis of the matrix protein of Borna disease virus. Acta
Crystallogr. D Biol. Crystallogr. 58, 1371–1373.
[21] Creighton, T.E. (1997) Protein Structure, Practical Approach
Series, second ed, Oxford University Press.
[22] Laemmli, U.K. (1970) Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 227, 680–685.
[23] Siegel, L.M. and Monty, K.J. (1966) Determination of molecular
weights and frictional ratios of proteins in impure systems by use
of gel ﬁltration and density gradient centrifugation. Application
to crude preparations of sulﬁte and hydroxylamine reductases.
Biochim. Biophys. Acta 112, 346–362.
[24] Luther, M.A., Cai, G.Z. and Lee, L.C. (1986) Thermodynamics of
dimer tetramer formations in rabbit muscle phosphofructokinase.
Biochemistry 25, 7931–7937.
[25] Dittmer, A. and Bogner, E. (2005) Analysis of the quaternary
structure of the putative HCMV portal protein pUL104. Bio-
chemistry 44, 759–765.
[26] Zipper, P., Kratky, O., Herrmann, R. and Hohn, T. (1971) An X-
ray small angle study of the bacteriophages fr and R17. Eur. J.
Biochem. 18, 1–9.[27] Briggs, J.A., Wilk, T. and Fuller, S.D. (2003) Do lipid rafts
mediate virus assembly and pseudotyping?. J. Gen. Virol. 84, 757–
768.
[28] Demirov, D.G. and Freed, E.O. (2004) Retrovirus budding. Virus
Res. 106, 87–102.
[29] Rudolph, M.G., Kraus, I., Dickmanns, A., Eickmann, M.,
Garten, W. and Ficner, R. (2003) Crystal structure of the
borna disease virus nucleoprotein. Structure (Camb) 11, 1219–
1226.
[30] Arzt, S., Baudin, F., Barge, A., Timmins, P., Burmeister, W.P.
and Ruigrok, R.W. (2001) Combined results from solution studies
on intact inﬂuenza virus M1 protein and from a new crystal form
of its N-terminal domain show that M1 is an elongated monomer.
Virology 279, 439–446.
[31] Gaudin, Y., Barge, A., Ebel, C. and Ruigrok, R.W. (1995)
Aggregation of VSV M protein is reversible and mediated by
nucleation sites: implications for viral assembly. Virology 206, 28–
37.
[32] Timmins, J., Schoehn, G., Kohlhaas, C., Klenk, H.D., Ruigrok,
R.W. and Weissenhorn, W. (2003) Oligomerization and polymer-
ization of the ﬁlovirus matrix protein VP40. Virology 312, 359–
368.
